Search by Drug Name or NDC
NDC 10019-0672-10 BREVIBLOC 10 mg/mL Details
BREVIBLOC 10 mg/mL
BREVIBLOC is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is ESMOLOL HYDROCHLORIDE.
Product Information
| NDC | 10019-0672 |
|---|---|
| Product ID | 10019-672_44616775-cf16-4111-b069-fdaabf267791 |
| Associated GPIs | 33200025112020 |
| GCN Sequence Number | 048856 |
| GCN Sequence Number Description | esmolol in sodium chloride,iso IV SOLN 2500MG/250 INTRAVEN |
| HIC3 | J7C |
| HIC3 Description | BETA-ADRENERGIC BLOCKING AGENTS |
| GCN | 14799 |
| HICL Sequence Number | 025126 |
| HICL Sequence Number Description | ESMOLOL HCL IN SODIUM CHLORIDE, ISO-OSMOTIC |
| Brand/Generic | Brand |
| Proprietary Name | BREVIBLOC |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | esmolol hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/mL |
| Substance Name | ESMOLOL HYDROCHLORIDE |
| Labeler Name | Baxter Healthcare Corporation |
| Pharmaceutical Class | Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA019386 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 10019-0672-10 (10019067210)
| NDC Package Code | 10019-672-10 |
|---|---|
| Billing NDC | 10019067210 |
| Package | 10 BAG in 1 CARTON (10019-672-10) / 250 mL in 1 BAG |
| Marketing Start Date | 2018-01-31 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |